Product News

Ortho Clinical Diagnostics Unveils Next-Generation Analyzer and Shares Research on IVDs for Application in Cardiology, Infectious Disease, Endocrinology

At the annual meeting of the American Association for Clinical Chemistry, Ortho showcased its new VITROS® XT 7600 Integrated System

Ortho Clinical Diagnostics
Ortho Clinical Diagnostics Unveils Next-Generation Analyzer and Shares Research on IVDs for Application in Cardiology, Infectious Disease, Endocrinology

The VITROS® XT 7600 removes the obstacles to reducing turnaround time and increasing your ability to provide meaningful results

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, officially unveiled the VITROS® XT 7600 Integrated System*, now available in numerous countries that accept CE Mark, at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo. It also presented seven scientific posters highlighting performance of assays that are part of its offerings for sepsis, Chagas, diabetes, and other conditions. In addition to the VITROS® XT 7600*, Ortho displayed additional clinical lab and immunohematology analyzers and other solutions in its booth (No. 612). The conference was held July 29-August 2 at the McCormick Place convention center in Chicago. 

“Ortho is committed to innovation that helps our customers achieve their goals of enhancing medical value while increasing efficiency,” said Robert Yates, chief operating officer for Ortho. “We’re delighted to officially reveal at AACC Ortho’s VITROS® XT 7600*, which introduces fundamental change to the way labs operate, and to present insightful posters in the areas of cardiology, infectious disease and endocrinology.”

In addition to its seven posters, Ortho collaborated with partners on the following research that was presented at AACC:

  • Performance of Diazyme Lp(a) Assay Assay on the VITROS® 4600 Chemistry System and the VITROS® 5600 Integrated System
  • Performance of the Diazyme Laboratories Inc. Glycated Serum Protein Assay on the VITROS® 4600 Chemistry System and the VITROS® 5600 Integrated System
  • Performance of a five member panel of Bio-Rad Laboratories HIV Quality Controls on the Ortho VITROS® HIV Combo assay

Ortho’s latest analyzer to receive CE Mark, the VITROS® XT 7600 Integrated System*, combines proprietary dry slide technology with sophisticated digital imaging capabilities and the potential to perform two separate lab tests simultaneously, introducing digital chemistry to clinical lab management.

Additional products that were on display at Ortho’s booth included VITROS® 3600 Immunodiagnostic Systems, VITROS® 4600 Chemistry Systems, VITROS® 5600 Integrated Systems, VITROS® Automation Solutions and immunohematology analyzers, ORTHO VISION® and ORTHO VISION® Max.

 

* In Development – Not approved or cleared in the United States

Product availability subject to local regulatory requirements

To learn more about this product, click below:
Learn More

Ortho Clinical Diagnostics

1001 Route 202 Raritan, NJ 08869 USA